For the quarter ending 2025-09-30, CABA made $48,916K in revenue. -$44,844K in net income. Net profit margin of -91.68%.
| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Research and development | 39,824 | 37,638 | ||
| General and administrative | 6,764 | 8,268 | ||
| Total operating expenses | 46,588 | 45,906 | ||
| Loss from operations | -46,588 | -45,906 | ||
| Interest income | 1,808 | 1,410 | ||
| Interest expense | 584 | 571 | ||
| Other income, net | 498 | -61 | ||
| Net loss | -44,866 | -45,128 | ||
| Net unrealized gain (loss) on available-for-sale investments, net of tax | 22 | 1 | ||
| Net comprehensive loss | -44,844 | -45,127 | ||
| Net loss per share, basic | -0.44 | -0.73 | ||
| Net loss per share, diluted | -0.44 | -0.73 | ||
Cabaletta Bio, Inc. (CABA)
Cabaletta Bio, Inc. (CABA)